SEC Form 4 · accession 0001104659-16-096010
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Michael Cashman
Officer — President and CEO · Director
Period of report
Nov 6, 2015
Accepted (ET)
Feb 11, 2016 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 6, 2015 | P | 3,561 | $5.61 | A | 116,085 | D | |
| Common Stock | Feb 9, 2016 | M | 24,684 | $1.04 | A | 140,769 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $1.04 | Feb 9, 2016 | M | 24,684 | D | — | Apr 4, 2023 | Common Stock | 24,684 | 31,662 | D |
Explanation of responses
- F117,596 shares vested on 04/04/2013; remaining shares vest in 43 equal monthly installments